Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?-Reference-Cited by-同舟云学术

Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?

Published:2017-03-08 Issue:3 Volume:12 Page:e0171552
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lee De-Hyung,Seubert Silvia,Huhn Konstantin,Brecht Lukas,Rötger Caroline,Waschbisch Anne,Schlachetzki Johannes,Klausmeyer Alice,Melms Arthur,Wiese Stefan,Winkler Jürgen,Linker Ralf A.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation;E Herrero-Herranz;Am J Pathol,2007

2. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis;E Herrero-Herranz;Neurobiol Dis,2008

3. Molecular and cellular mechanisms of excitotoxic neuronal death;Y Wang;Apoptosis,2010

4. Glutamate uptake;NC Danbolt;Prog Neurobiol,2001

5. Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: A mechanism mediated by tumor necrosis factor-alpha;T Korn;FASEB J,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Fingolimod Loaded Sodium Alginate Nanoparticles and Investigation of Efficacy on Membrane Damage Induced Human U- 87 MG Glioma Cell;2024-07-02

2. Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake Assays;ACS Chemical Neuroscience;2024-03-13

3. Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration;Nature Reviews Neurology;2023-06-12

4. Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial;Schizophrenia Research;2023-04

5. Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis;Immunology;2022-09-04